Performance evaluation of SARS-CoV-2 rapid diagnostic tests in Nigeria: A cross-sectional study.
The COVID-19 pandemic challenged health systems globally. Reverse transcription polymerase chain reaction (RT-PCR) is the gold standard for detecting the presence of SARS-CoV-2 in clinical samples. Rapid diagnostic test (RDT) kits for COVID-19 have been widely used in Nigeria. This has greatly impro...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLOS Global Public Health |
| Online Access: | https://doi.org/10.1371/journal.pgph.0003371 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849331916384239616 |
|---|---|
| author | Akhere A Omonkhua Adedayo Faneye Kazeem S Akinwande Okpokoro Evaezi Nathan Y Shehu Adedeji Onayade Chinwe Lucia Ochu Mustapha Popoola Nnadi Emmanuel Temitope Ojo Cornelius Ohonsi Abdullahi Abubakar Elizabeth Odeh Paul Akinduti Onikepe Folarin John Samson Bimba Ehimario Igumbor Kelly Elimian Victory Fabian Edem Luka Pam D Tunde Olusola Loretta Ntoimo Michael Olugbile Adewale Victor Opayele Ibrahim Kida Shwe David Augustine Onyeaghala Isaac Igbarumah Omosivie Maduka Magaji A Mahmoud Abdul Rahman El-Fulatty David O Olaleye Omale Simon Iriagbonse Iyabo Osaigbovo Darlington Ewaen Obaseki Afolaranmi Tolulupe Christian Happi Yusuf Bara Jibrin Friday Okonofua Timan Eliya Gomerep Simji Izang Joy Abi Emmanuel Ameh Ibrahim Mahmood Maigari Sulaiman Alhaji Ifedayo Adetifa Babatunde Salako Suleiman Bogoro Chikwe Ihekweazu Georgina N Odaibo COVID-19 RDT Validation in Nigeria (CORVAN) study group |
| author_facet | Akhere A Omonkhua Adedayo Faneye Kazeem S Akinwande Okpokoro Evaezi Nathan Y Shehu Adedeji Onayade Chinwe Lucia Ochu Mustapha Popoola Nnadi Emmanuel Temitope Ojo Cornelius Ohonsi Abdullahi Abubakar Elizabeth Odeh Paul Akinduti Onikepe Folarin John Samson Bimba Ehimario Igumbor Kelly Elimian Victory Fabian Edem Luka Pam D Tunde Olusola Loretta Ntoimo Michael Olugbile Adewale Victor Opayele Ibrahim Kida Shwe David Augustine Onyeaghala Isaac Igbarumah Omosivie Maduka Magaji A Mahmoud Abdul Rahman El-Fulatty David O Olaleye Omale Simon Iriagbonse Iyabo Osaigbovo Darlington Ewaen Obaseki Afolaranmi Tolulupe Christian Happi Yusuf Bara Jibrin Friday Okonofua Timan Eliya Gomerep Simji Izang Joy Abi Emmanuel Ameh Ibrahim Mahmood Maigari Sulaiman Alhaji Ifedayo Adetifa Babatunde Salako Suleiman Bogoro Chikwe Ihekweazu Georgina N Odaibo COVID-19 RDT Validation in Nigeria (CORVAN) study group |
| author_sort | Akhere A Omonkhua |
| collection | DOAJ |
| description | The COVID-19 pandemic challenged health systems globally. Reverse transcription polymerase chain reaction (RT-PCR) is the gold standard for detecting the presence of SARS-CoV-2 in clinical samples. Rapid diagnostic test (RDT) kits for COVID-19 have been widely used in Nigeria. This has greatly improved test turnover rates and significantly decreased the high technical demands of RT-PCR. However, there is currently no nationally representative evaluation of the performance characteristics and reliability of these kits. This study assessed the sensitivity, specificity, and predictive values of ten RDT kits used for COVID-19 testing in Nigeria. This large multi-centred cross-sectional study was conducted across the 6 geo-political zones of Nigeria over four months. Ten antigen (Ag) and antibody (Ab) RDT kits were evaluated, and the results were compared with RT-PCR. One thousand, three hundred and ten (1,310) consenting adults comprising 767 (58.5%) males and 543 (41.5%) females participated in the study. The highest proportion, 757 (57.7%), were in the 20-39 years' age group. In terms of diagnostic performance, Lumira Dx (61.4, 95% CI: 52.4-69.9) had the highest sensitivity while MP SARS and Panbio (98.5, 95% CI: 96.6-99.5) had the highest specificity. For predictive values, Panbio (90.7, 95% CI: 79.7-96.9) and Lumira Dx (81.2, 95% CI: 75.9-85.7) recorded the highest PPV and NPV respectively. Ag-RDTs had better performance characteristics compared with Ab-RDTs; however, the sensitivities of all RDTs in this study were generally low. The relatively high specificity of Ag-RDTs makes them useful for the diagnosis of infection in COVID-19 suspected cases where positive RDT may not require confirmation by molecular testing. There is therefore the need to develop RDTs in-country that will take into consideration the unique environmental factors, interactions with other infectious agents, and strains of the virus circulating locally. This may enhance the precision of rapid and accurate diagnosis of COVID-19 in Nigeria. |
| format | Article |
| id | doaj-art-c7253d312fa5432eab9cdd80f7c4eccb |
| institution | Kabale University |
| issn | 2767-3375 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLOS Global Public Health |
| spelling | doaj-art-c7253d312fa5432eab9cdd80f7c4eccb2025-08-20T03:46:21ZengPublic Library of Science (PLoS)PLOS Global Public Health2767-33752024-01-0147e000337110.1371/journal.pgph.0003371Performance evaluation of SARS-CoV-2 rapid diagnostic tests in Nigeria: A cross-sectional study.Akhere A OmonkhuaAdedayo FaneyeKazeem S AkinwandeOkpokoro EvaeziNathan Y ShehuAdedeji OnayadeChinwe Lucia OchuMustapha PopoolaNnadi EmmanuelTemitope OjoCornelius OhonsiAbdullahi AbubakarElizabeth OdehPaul AkindutiOnikepe FolarinJohn Samson BimbaEhimario IgumborKelly ElimianVictory Fabian EdemLuka Pam DTunde OlusolaLoretta NtoimoMichael OlugbileAdewale Victor OpayeleIbrahim KidaShwe DavidAugustine OnyeaghalaIsaac IgbarumahOmosivie MadukaMagaji A MahmoudAbdul Rahman El-FulattyDavid O OlaleyeOmale SimonIriagbonse Iyabo OsaigbovoDarlington Ewaen ObasekiAfolaranmi TolulupeChristian HappiYusuf Bara JibrinFriday OkonofuaTiman EliyaGomerep SimjiIzang Joy AbiEmmanuel AmehIbrahim Mahmood MaigariSulaiman AlhajiIfedayo AdetifaBabatunde SalakoSuleiman BogoroChikwe IhekweazuGeorgina N OdaiboCOVID-19 RDT Validation in Nigeria (CORVAN) study groupThe COVID-19 pandemic challenged health systems globally. Reverse transcription polymerase chain reaction (RT-PCR) is the gold standard for detecting the presence of SARS-CoV-2 in clinical samples. Rapid diagnostic test (RDT) kits for COVID-19 have been widely used in Nigeria. This has greatly improved test turnover rates and significantly decreased the high technical demands of RT-PCR. However, there is currently no nationally representative evaluation of the performance characteristics and reliability of these kits. This study assessed the sensitivity, specificity, and predictive values of ten RDT kits used for COVID-19 testing in Nigeria. This large multi-centred cross-sectional study was conducted across the 6 geo-political zones of Nigeria over four months. Ten antigen (Ag) and antibody (Ab) RDT kits were evaluated, and the results were compared with RT-PCR. One thousand, three hundred and ten (1,310) consenting adults comprising 767 (58.5%) males and 543 (41.5%) females participated in the study. The highest proportion, 757 (57.7%), were in the 20-39 years' age group. In terms of diagnostic performance, Lumira Dx (61.4, 95% CI: 52.4-69.9) had the highest sensitivity while MP SARS and Panbio (98.5, 95% CI: 96.6-99.5) had the highest specificity. For predictive values, Panbio (90.7, 95% CI: 79.7-96.9) and Lumira Dx (81.2, 95% CI: 75.9-85.7) recorded the highest PPV and NPV respectively. Ag-RDTs had better performance characteristics compared with Ab-RDTs; however, the sensitivities of all RDTs in this study were generally low. The relatively high specificity of Ag-RDTs makes them useful for the diagnosis of infection in COVID-19 suspected cases where positive RDT may not require confirmation by molecular testing. There is therefore the need to develop RDTs in-country that will take into consideration the unique environmental factors, interactions with other infectious agents, and strains of the virus circulating locally. This may enhance the precision of rapid and accurate diagnosis of COVID-19 in Nigeria.https://doi.org/10.1371/journal.pgph.0003371 |
| spellingShingle | Akhere A Omonkhua Adedayo Faneye Kazeem S Akinwande Okpokoro Evaezi Nathan Y Shehu Adedeji Onayade Chinwe Lucia Ochu Mustapha Popoola Nnadi Emmanuel Temitope Ojo Cornelius Ohonsi Abdullahi Abubakar Elizabeth Odeh Paul Akinduti Onikepe Folarin John Samson Bimba Ehimario Igumbor Kelly Elimian Victory Fabian Edem Luka Pam D Tunde Olusola Loretta Ntoimo Michael Olugbile Adewale Victor Opayele Ibrahim Kida Shwe David Augustine Onyeaghala Isaac Igbarumah Omosivie Maduka Magaji A Mahmoud Abdul Rahman El-Fulatty David O Olaleye Omale Simon Iriagbonse Iyabo Osaigbovo Darlington Ewaen Obaseki Afolaranmi Tolulupe Christian Happi Yusuf Bara Jibrin Friday Okonofua Timan Eliya Gomerep Simji Izang Joy Abi Emmanuel Ameh Ibrahim Mahmood Maigari Sulaiman Alhaji Ifedayo Adetifa Babatunde Salako Suleiman Bogoro Chikwe Ihekweazu Georgina N Odaibo COVID-19 RDT Validation in Nigeria (CORVAN) study group Performance evaluation of SARS-CoV-2 rapid diagnostic tests in Nigeria: A cross-sectional study. PLOS Global Public Health |
| title | Performance evaluation of SARS-CoV-2 rapid diagnostic tests in Nigeria: A cross-sectional study. |
| title_full | Performance evaluation of SARS-CoV-2 rapid diagnostic tests in Nigeria: A cross-sectional study. |
| title_fullStr | Performance evaluation of SARS-CoV-2 rapid diagnostic tests in Nigeria: A cross-sectional study. |
| title_full_unstemmed | Performance evaluation of SARS-CoV-2 rapid diagnostic tests in Nigeria: A cross-sectional study. |
| title_short | Performance evaluation of SARS-CoV-2 rapid diagnostic tests in Nigeria: A cross-sectional study. |
| title_sort | performance evaluation of sars cov 2 rapid diagnostic tests in nigeria a cross sectional study |
| url | https://doi.org/10.1371/journal.pgph.0003371 |
| work_keys_str_mv | AT akhereaomonkhua performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT adedayofaneye performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT kazeemsakinwande performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT okpokoroevaezi performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT nathanyshehu performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT adedejionayade performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT chinweluciaochu performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT mustaphapopoola performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT nnadiemmanuel performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT temitopeojo performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT corneliusohonsi performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT abdullahiabubakar performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT elizabethodeh performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT paulakinduti performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT onikepefolarin performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT johnsamsonbimba performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT ehimarioigumbor performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT kellyelimian performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT victoryfabianedem performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT lukapamd performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT tundeolusola performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT lorettantoimo performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT michaelolugbile performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT adewalevictoropayele performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT ibrahimkida performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT shwedavid performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT augustineonyeaghala performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT isaacigbarumah performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT omosiviemaduka performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT magajiamahmoud performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT abdulrahmanelfulatty performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT davidoolaleye performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT omalesimon performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT iriagbonseiyaboosaigbovo performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT darlingtonewaenobaseki performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT afolaranmitolulupe performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT christianhappi performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT yusufbarajibrin performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT fridayokonofua performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT timaneliya performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT gomerepsimji performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT izangjoyabi performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT emmanuelameh performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT ibrahimmahmoodmaigari performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT sulaimanalhaji performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT ifedayoadetifa performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT babatundesalako performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT suleimanbogoro performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT chikweihekweazu performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT georginanodaibo performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy AT covid19rdtvalidationinnigeriacorvanstudygroup performanceevaluationofsarscov2rapiddiagnostictestsinnigeriaacrosssectionalstudy |